View Older Stories View More Recent Stories
-
NovaBay Pharma (NBY) Prices 5.9M Common Offering at $1.25/Share
-
NovaBay Pharma (NBY) Announces Common Offering
-
Lazard Capital Starts Supernus Pharmaceuticals (SUPN) at Buy
-
Lazard Capital Starts Covanta (CVA) at Buy
-
CreXus Investment (CXS) Taps Lazard to Advise on Annaly (NLY) Bid
-
Raymond James Starts Lazard (LAZ) at Outperform
-
Analysts, Physicians Positive on FDA Approval of Exelixis' (EXEL) Cabozantinib into Meeting
-
Notable Analyst Rating Changes 11/26: (RIMM) (YHOO) (FB) Upgraded; (MCD) (ARO) (ILMN) Downgraded
-
Lazard Capital Downgrades McDonald's (MCD) to Neutral
-
Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded
-
Lazard Capital Upgrades Penn National Gaming (PENN) to Buy
-
Lazard Capital Starts WellPoint (WLP) at Neutral
-
Lazard Capital Starts UnitedHealth Group (UNH) at Buy
-
Lazard Capital Starts Aetna (AET) at Buy
-
CNH Global (CNH) Affirms Fiat Industrial Bid; Will Review Proposal
-
Notable Mergers and Acquisitions of the Day 11/16: (PENN) (SHF) (OUTD) (HTZ)/(DTG) More...
-
Outdoor Channel (OUTD) Enters Merger with InterMedia Outdoors
-
Stocks Crossing 50-Day SMA 11/13: (DVAX) (ARNA) (DKS) Above; (CELG) (ALU) (PMT) Below
-
Notable Analyst Rating Changes 11/13: (ALB) (EV) (DDD) Upgraded; (MCP) (LYB) (JNS) Downgraded
-
Lazard Capital Starts Berry Plastics Group (BERY) at Buy
-
Unusual 11 Mid-Day Movers 11/12: (TIE) (STV) (LDK) Higher; (GALE) (CLVS) (STSI) Lower
-
Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
-
Lazard Capital Downgrades Kayak Software (KYAK) to Neutral
-
Lazard Capital Downgrades Progenics Pharmaceuticals (PGNX) to Neutral
-
Lazard Capital Downgrades STEC, Inc. (STEC) to Neutral
-
Lazard Capital Upgrades Demandware (DWRE) to Buy
-
Lazard Capital Starts Kythera Biopharmaceuticals (KYTH) at Buy
-
MSCI (MSCI) Unit to Acquire IPD Group in $125M Deal
-
Notable Analyst Rating Changes 10/26: (CSTR) (CME) (PG) Upgraded; (CLF) (CAT) (CTCT) Downgraded
-
Lazard Capital Downgrades Starwood Hotels & Resorts (HOT) to Neutral
-
Lazard Capital Upgrades Varian Medical (VAR) to Buy
-
Lazard Capital Downgrades Constant Contact (CTCT) to Neutral
-
Lazard (LAZ) Tops Q3 EPS by 4c
-
Lazard Capital Downgrades TriQuint Semiconductor (TQNT) to Neutral
-
Trading Radar for 10/25: Apple (AAPL), Sprint (S), Amazon (AMZN), Clearwire (CLWR), Procter & Gamble (PG), Dunkin' Brands (DNKN), Expedia (EXPE) Report
-
Lazard Class A (LAZ) Declares $0.20 Quarterly Dividend; 2.8% Yield
-
Lazard Capital Starts Bazaarvoice (BV) at Neutral
-
Notable Analyst Rating Changes 10/22: (BBT) (BEAM) (AMGN) Upgraded; (SNDK) (DDR) (TLM) Downgraded
-
Lazard Capital Starts Qualys (QLYS) at Buy
-
Notable Analyst Rating Changes 10/19: (ISRG) (ABT) (NOK) Upgraded; (NVDA) (JNS) (GOOG) Downgraded
-
A123 Systems (AONE) Receives Bankruptcy Court Approval to Use $15.5M of DIP Financing
-
Lazard Capital Starts Sunshine Heart (SSH) at Buy
-
Lazard Capital Downgrades Marvell (MRVL) to Neutral
-
ImmunoCellular (IMUC) Plans Public Offering
-
Notable Analyst Rating Changes 10/17: (FTNT) (C) (ORI) Upgraded; (MUR) (IBM) (CSCO) Downgraded
-
Lazard Capital Starts American Axle (AXL) at Neutral
-
Overseas Shipholding (OSG) Falls on Liquidity Fears
-
Stocks Crossing 50-Day SMA 10/15: (RF) (SNDK) (CSCO) Above; (EBAY) (DCTH) (HRS) Below
-
Lazard Capital Downgrades Harris Corp. (HRS) to Sell
-
IPO for "Double Chin" Solver KYTHERA Biopharmaceuticals (KYTH) iPO Opens 16% Higher

